Johnson & Johnson Cv Rx, Inc. Transaction History
Johnson & Johnson
- $427 Million
- Q3 2025
A detailed history of Johnson & Johnson transactions in Cv Rx, Inc. stock. As of the latest transaction made, Johnson & Johnson holds 4,103,430 shares of CVRX stock, worth $37.3 Million. This represents 7.51% of its overall portfolio holdings.
Number of Shares
4,103,430
Previous 4,103,430
-0.0%
Holding current value
$37.3 Million
Previous $24.1 Million
32.99%
% of portfolio
7.51%
Previous 8.12%
Shares
2 transactions
Others Institutions Holding CVRX
# of Institutions
95Shares Held
14.3MCall Options Held
59.5KPut Options Held
30.3K-
Nea Management Company, LLC Timonium, MD2.03MShares$18.4 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.09MShares$9.92 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$7.97 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL696KShares$6.34 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT491KShares$4.47 Million0.48% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $187M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...